Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:43:32 EDT Fri 20 Jun 2025
Enter Symbol
or Name
USA
CA



Q:FBIO - FORTRESS BIOTECH INC - https://fortressbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FBIO - Q0.11.61·2.471.01.81-0.02-1.1129.31.81  1.87  1.792.887  1.325Jun 18Jun 0915 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-09 08:30U:FBIONews ReleaseJourney Medical Corporation Announces Emrosi(TM) Featured on "The Balancing Act" Airing on Lifetime TV
2025-05-30 10:48U:FBIONews ReleaseFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
2025-05-15 16:05U:FBIONews ReleaseFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-14 16:02U:FBIONews ReleaseJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 16:16U:FBIONews ReleaseCheckpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
2025-05-07 16:01U:FBIONews ReleaseJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
2025-05-07 08:00U:FBIONews ReleaseFortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
2025-04-01 16:01U:FBIONews ReleaseJourney Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
2025-03-31 16:05U:FBIONews ReleaseFortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
2025-03-28 08:30U:FBIONews ReleaseCheckpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
2025-03-26 16:01U:FBIONews ReleaseJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
2025-03-24 08:30U:FBIONews ReleaseJourney Medical Corporation Launches Emrosi(TM) (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
2025-03-19 16:02U:FBIONews ReleaseJourney Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
2025-03-17 08:56U:FBIONews ReleasePartex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
2025-03-12 08:31U:FBIONews ReleaseJourney Medical Corporation to Participate in the 37th Annual ROTH Conference
2025-03-09 22:06U:FBIONews ReleaseSun Pharma to Acquire Checkpoint Therapeutics
2025-03-05 16:15U:FBIONews ReleaseMustang Bio Regains Compliance with Nasdaq Capital Market Requirement
2025-03-05 16:01U:FBIONews ReleaseJourney Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi(TM) (DFD-29) to Treat Rosacea
2025-03-04 16:02U:FBIONews ReleaseJourney Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
2025-02-27 16:05U:FBIONews ReleaseMustang Bio Announces Sale of Fixed Assets and Exit of Facility